NexturnBioscience Co. Ltd
Nexturn Co.,Ltd. develops and produces CNC automatic lathe machines in Korea and internationally. It provides CNC swiss-type automatic lathe products, high temperature display glass press equipment, and automatic line-up robots, as well as an intelligent intervention robot system based on robot 3D cardiovascular visualization technology. The company was formerly known as KMT Incorporated and chan… Read more
Market Cap & Net Worth: NexturnBioscience Co. Ltd (089140)
NexturnBioscience Co. Ltd (KQ:089140) has a market capitalization of $15.92 Million (₩23.32 Billion) as of March 18, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #24129 globally and #1360 in its home market, demonstrating a 2.76% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying NexturnBioscience Co. Ltd's stock price ₩2235.00 by its total outstanding shares 10432100 (10.43 Million).
NexturnBioscience Co. Ltd Market Cap History: 2015 to 2026
NexturnBioscience Co. Ltd's market capitalization history from 2015 to 2026. Data shows change from $92.12 Million to $15.92 Million (-16.28% CAGR).
Index Memberships
NexturnBioscience Co. Ltd is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Kosdaq Composite Index
KOSDAQ
|
$167.85 Billion | 0.02% | #679 of 1384 |
|
Kosdaq Composite Index
KQ11
|
$167.85 Billion | 0.02% | #679 of 1384 |
Weight: NexturnBioscience Co. Ltd's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
NexturnBioscience Co. Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how NexturnBioscience Co. Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
NexturnBioscience Co. Ltd's market cap is 0.00 times its annual revenue
0.00x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $92.12 Million | $16.18 Billion | $1.36 Billion | 0.01x | 0.07x |
| 2016 | $299.46 Million | $74.37 Billion | $17.17 Billion | 0.00x | 0.02x |
| 2017 | $155.82 Million | $43.71 Billion | $6.78 Billion | 0.00x | 0.02x |
| 2018 | $129.79 Million | $26.65 Billion | $5.55 Billion | 0.00x | 0.02x |
| 2019 | $122.85 Million | $32.45 Billion | $5.76 Billion | 0.00x | 0.02x |
| 2020 | $141.31 Million | $9.69 Billion | -$2.44 Billion | 0.01x | N/A |
| 2021 | $222.29 Million | $16.97 Billion | -$4.43 Billion | 0.01x | N/A |
| 2022 | $60.38 Million | $23.46 Billion | -$4.69 Billion | 0.00x | N/A |
| 2023 | $39.33 Million | $41.26 Billion | $9.68 Billion | 0.00x | 0.00x |
| 2024 | $19.91 Million | $31.64 Billion | -$13.00 Billion | 0.00x | N/A |
Competitor Companies of 089140 by Market Capitalization
Companies near NexturnBioscience Co. Ltd in the global market cap rankings as of March 18, 2026.
Key companies related to NexturnBioscience Co. Ltd by market ranking:
- Neles Oyj (HE:METSO_old): Ranked #2101 globally with a market cap of $7.35 Billion USD ( €7.16 Billion EUR).
- NIBE Industrier AB ser. B (SW:NIBEB): Ranked #3047 globally with a market cap of $4.38 Billion USD ( CHF4.01 Billion CHF).
- SPG Co. Ltd (KQ:058610): Ranked #6748 globally with a market cap of $1.15 Billion USD ( ₩1.69 Trillion KRW).
- Hyulim ROBOT Co.Ltd (KQ:090710): Ranked #6788 globally with a market cap of $1.14 Billion USD ( ₩1.67 Trillion KRW).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #2101 | Neles Oyj | HE:METSO_old | $7.35 Billion | €11.27 |
| #3047 | NIBE Industrier AB ser. B | SW:NIBEB | $4.38 Billion | CHF2.87 |
| #6748 | SPG Co. Ltd | KQ:058610 | $1.15 Billion | ₩125000.00 |
| #6788 | Hyulim ROBOT Co.Ltd | KQ:090710 | $1.14 Billion | ₩13440.00 |
NexturnBioscience Co. Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, NexturnBioscience Co. Ltd's market cap moved from $92.12 Million to $ 15.92 Million, with a yearly change of -16.28%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩15.92 Million | +2.76% |
| 2025 | ₩15.50 Million | -22.18% |
| 2024 | ₩19.91 Million | -49.37% |
| 2023 | ₩39.33 Million | -34.87% |
| 2022 | ₩60.38 Million | -72.84% |
| 2021 | ₩222.29 Million | +57.31% |
| 2020 | ₩141.31 Million | +15.03% |
| 2019 | ₩122.85 Million | -5.35% |
| 2018 | ₩129.79 Million | -16.70% |
| 2017 | ₩155.82 Million | -47.97% |
| 2016 | ₩299.46 Million | +225.07% |
| 2015 | ₩92.12 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of NexturnBioscience Co. Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $15.92 Million USD |
| MoneyControl | $15.92 Million USD |
| MarketWatch | $15.92 Million USD |
| marketcap.company | $15.92 Million USD |
| Reuters | $15.92 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.